Enterprise Value
0.00
Cash
0.00
Avg Qtr Burn
N/A
Short % of Float
0.00%
Insider Ownership
0.00%
Institutional Own.
0.00%
Qtr Updated
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Approved Quarterly sales | ||
XIAFLEX (injectable CCH (collagenase clostridium histolyticum)) Details Dupuytren's contracture, Peyronie's disease, Adhesive capsulitis | Approved Quarterly sales | |
Collagen clostridium histolyticum (CCH) Details Plantar Fibromatosis | Phase 3 Initiation |